Innovator IBD Price To Sales vs. Last Dividend Paid
| FFTY Etf | USD 31.64 0.41 1.31% |
For Innovator IBD profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Innovator IBD to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Innovator IBD 50 utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Innovator IBD's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Innovator IBD 50 over time as well as its relative position and ranking within its peers.
Innovator |
The market value of Innovator IBD 50 is measured differently than its book value, which is the value of Innovator that is recorded on the company's balance sheet. Investors also form their own opinion of Innovator IBD's value that differs from its market value or its book value, called intrinsic value, which is Innovator IBD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovator IBD's market value can be influenced by many factors that don't directly affect Innovator IBD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovator IBD's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innovator IBD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovator IBD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Innovator IBD 50 Last Dividend Paid vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Innovator IBD's current stock value. Our valuation model uses many indicators to compare Innovator IBD value to that of its competitors to determine the firm's financial worth. Innovator IBD 50 is one of the top ETFs in price to sales as compared to similar ETFs. It also is one of the top ETFs in last dividend paid as compared to similar ETFs creating about 0.02 of Last Dividend Paid per Price To Sales. The ratio of Price To Sales to Last Dividend Paid for Innovator IBD 50 is roughly 65.85 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Innovator IBD's earnings, one of the primary drivers of an investment's value.Innovator Last Dividend Paid vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Innovator IBD |
| = | 3.74 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
Innovator IBD |
| = | 0.0568 |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Innovator Last Dividend Paid Comparison
Innovator IBD is currently under evaluation in last dividend paid as compared to similar ETFs.
Innovator IBD Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Innovator IBD, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Innovator IBD will eventually generate negative long term returns. The profitability progress is the general direction of Innovator IBD's change in net profit over the period of time. It can combine multiple indicators of Innovator IBD, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
The fund will normally invest at least 80 percent of its net assets in securities that comprise the index. Innovator Ibd is traded on NYSEARCA Exchange in the United States.
Innovator Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Innovator IBD. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Innovator IBD position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Innovator IBD's important profitability drivers and their relationship over time.
Use Innovator IBD in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Innovator IBD position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator IBD will appreciate offsetting losses from the drop in the long position's value.Innovator IBD Pair Trading
Innovator IBD 50 Pair Trading Analysis
The ability to find closely correlated positions to Innovator IBD could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Innovator IBD when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Innovator IBD - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Innovator IBD 50 to buy it.
The correlation of Innovator IBD is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Innovator IBD moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Innovator IBD 50 moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Innovator IBD can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Innovator IBD position
In addition to having Innovator IBD in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Exotic Funds Thematic Idea Now
Exotic Funds
Funds or Etfs with high minimum investment requirement that manage portfolios of alternative investments such as hedge funds, options, futures, real estate or commodities. The Exotic Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Exotic Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
To fully project Innovator IBD's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Innovator IBD 50 at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Innovator IBD's income statement, its balance sheet, and the statement of cash flows.